QuickView for transforming growth factor beta receptor activity, type II (biogroup)

1. L1000 CMAP - Neuronal NEU cells treated with small molecule perturbagens
2. L1000 CMAP - Bone marrow CD34 cells treated with small molecule perturbagens
3. L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (3 of 4)
4. L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)
5. L1000 CMAP - Neural progenitor NPC.CAS9 cells treated with small molecule perturbagens

There were no matches for transforming growth factor beta receptor activity, type II

1. Angiotensin II Antagonism of TGF-Beta 1
2. Renoprotection by Pentoxifylline and Angiotensin Receptor Blocker in Chronic Kidney Disease (CKD)
3. Galunisertib and Paclitaxel in Treating Patients With Metastatic Androgen Receptor Negative (AR-) Tr…
4. Sotrastaurin Acetate in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia, …
5. Time-limited Triplet Combination of Pirtobrutinib, Venetoclax, and Obinutuzumab for Patients With Tr…